| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.07 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.27 | 0.07 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |